AAV1/2-mediated CNS gene delivery of dominant-negative CCL2 mutant suppresses gliosis, β-amyloidosis, and learning impairment of APP/ PS1 mice

Tomomi Kiyota, Masaru Yamamoto, Bryce Schroder, Michael T. Jacobsen, Russell J. Swan, Mary P. Lambert, William L. Klein, Howard E. Gendelman, Richard M. Ransohoff, Tsuneya Ikezu

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'AAV1/2-mediated CNS gene delivery of dominant-negative CCL2 mutant suppresses gliosis, β-amyloidosis, and learning impairment of APP/ PS1 mice'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds